AEROMICS, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.aeromics.com
Phase 1 Study to Assess AER-271
Phase 1
Completed
- Conditions
- StrokeStroke, IschemicStroke, Acute
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Aeromics, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT03804476
- Locations
- 🇺🇸
Covance Dallas, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath